Age differences in cardiac remodeling, biomarkers and quality-of-life with sacubitril/valsartan in heart failure with reduced ejection fraction

被引：0
|
作者：
Murphy, S. [1 ]
Ward, J. H. [2 ]
Pina, I. L. [3 ]
Felker, G. M. [4 ]
Butler, J. [5 ]
Maisel, A. S. [6 ]
Meng, X. [2 ]
Prescott, M. F. [2 ]
Solomon, S. D. [7 ]
Januzzi, J. L. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Novartis, E Hanover, NJ USA
[3] Detroit Med Ctr, Detroit, MI USA
[4] Duke Univ, Med Ctr, Durham, NC 27706 USA
[5] Univ Mississippi, Med Ctr, Jackson, MS 39213 USA
[6] Univ Calif San Diego, San Diego, CA 92103 USA
[7] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [31] Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction
    Khan, Muhammad Nauman
    Soomro, Najia Aslam
    Naseeb, Khalid
    Bhatti, Usman Hanif
    Rauf, Rubina
    Balouch, Iram Jehan
    Moazzam, Ali
    Bashir, Sonia
    Ashraf, Tariq
    Karim, Musa
    [J]. BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [32] Sacubitril/valsartan reduces ventrucular arrhythmias in heart failure with reduced ejection fraction
    Lamaida, Norman
    Torella, Giorgio
    Cerciello, Antonio
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N26 - N26
  • [33] Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
    Lee, Ying-Hsiang
    Lin, Po-Lin
    Chiou, Wei-Ru
    Huang, Jin-Long
    Lin, Wen-Yu
    Liao, Chia-Te
    Chung, Fa-Po
    Liang, Huai-Wen
    Hsu, Chien-Yi
    Chang, Hung-Yu
    [J]. ESC HEART FAILURE, 2021, 8 (02): : 1204 - 1215
  • [34] Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
    Abumayyaleh, Mohammad
    El-Battrawy, Ibrahim
    Behnes, Michael
    Borggrefe, Martin
    Akin, Ibrahim
    [J]. FUTURE CARDIOLOGY, 2020, 16 (04) : 227 - 236
  • [35] Sacubitril/valsartan and low blood pressure in heart failure with reduced ejection fraction
    Bruno, Rosa Maria
    Taddei, Stefano
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (15) : 1144 - 1146
  • [36] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Liu, Rex C.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (06) : 473 - 482
  • [37] Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction
    Greene, Stephen J.
    Fonarow, Gregg C.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44 (31) : 2994 - 2997
  • [38] Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction
    Muhammad Nauman Khan
    Najia Aslam Soomro
    Khalid Naseeb
    Usman Hanif Bhatti
    Rubina Rauf
    Iram Jehan Balouch
    Ali Moazzam
    Sonia Bashir
    Tariq Ashraf
    Musa Karim
    [J]. BMC Cardiovascular Disorders, 23
  • [39] Atrial Natriuretic Peptide Mediates Reverse Cardiac Remodeling During Treatment with Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction
    Murphy, Sean P.
    Prescott, Margaret F.
    Camacho, Alexander
    Iyer, Seethalakshmi R.
    Maisel, Alan S.
    Felker, G. Michael
    Butler, Javed
    Pina, Ileana L.
    Ibrahim, Nasrien E.
    Abbas, Cheryl
    Burnett, John
    Solomon, Scott D.
    Januzzi, James L.
    [J]. JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S15 - S15
  • [40] Age Differences in Effects of Sacubitril/Valsartan on Cardiac Remodeling, Biomarkers, and Health Status
    Murphy, Sean P.
    Ward, Jonathan H.
    Pina, Ileana L.
    Felker, G. Michael
    Butler, Javed
    Maisel, Alan S.
    Meng, Xiangyi
    Prescott, Margaret F.
    Solomon, Scott D.
    Januzzi, James L.
    [J]. JACC-HEART FAILURE, 2022, 10 (12) : 976 - 988
12345